| 2025-11-25 |
详情>>
股本变动：
变动后总股本9775.29万股
|
| 2025-11-07 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.30美元,归母净利润2929.86万美元,同比去年增长613.67%
|
| 2025-11-06 |
财报披露：
美东时间 2025-11-06 盘后发布财报
|
| 2025-08-12 |
详情>>
业绩披露：
2025年中报每股收益0.23美元,归母净利润2222.33万美元,同比去年增长3939.79%
|
| 2025-08-06 |
详情>>
内部人交易：
Ganovsky Matthew股份减少1500000.00股
|
| 2025-05-08 |
详情>>
业绩披露：
2025年一季报每股收益0.05美元,归母净利润463.96万美元,同比去年增长443.99%
|
| 2025-04-28 |
股东大会：
将于2025-06-12召开股东大会
会议内容 ▼▲
- 1.To elect three Class II directors, Cornelis Michiel van Katwijk, Mary Beth Schulte and Karla Radka, to hold office until our annual meeting of stockholders in 2028 and until their successors are duly elected and qualified, or until their earlier death, resignation or removal;
2.To ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
3.To conduct any other business properly brought before the Annual Meeting.
|
| 2025-03-28 |
详情>>
业绩披露：
2024年年报每股收益-0.34美元,归母净利润-2396.11万美元,同比去年增长-351.78%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.09美元,归母净利润-570.38万美元,同比去年增长-136.24%
|
| 2024-08-12 |
详情>>
业绩披露：
2024年中报每股收益-0.01美元,归母净利润-57.88万美元,同比去年增长-103.9%
|
| 2024-05-30 |
详情>>
业绩披露：
2023年年报每股收益0.17美元,归母净利润951.66万美元,同比去年增长-69.96%
|
| 2024-05-13 |
详情>>
业绩披露：
2024年一季报每股收益-0.02美元,归母净利润-134.87万美元,同比去年增长-116.68%
|
| 2024-04-29 |
股东大会：
将于2024-06-13召开股东大会
会议内容 ▼▲
- 1.To elect two Class I directors, Sean McNealy and Adam Gusky, to hold office until our annual meeting of stockholders in 2027 and until their successors are duly elected and qualified, or until their earlier death, resignation or removal;
2.To ratify the selection of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
3.To consider and vote to adopt the Amended and Restated Abacus Life, Inc. 2024 Long-Term Equity Incentive Plan;
4.To conduct any other business properly brought before the Annual Meeting.
|
| 2024-01-02 |
复牌提示：
2024-01-02 09:30:16 停牌，复牌日期 2024-01-02 09:35:16
|
| 2023-11-13 |
详情>>
业绩披露：
2023年三季报(累计)每股收益0.29美元,归母净利润1573.90万美元,同比去年增长-26.82%
|
| 2023-08-14 |
详情>>
业绩披露：
2023年中报每股收益0.29美元,归母净利润1483.56万美元,同比去年增长28.83%
|
| 2023-06-14 |
股东大会：
将于2023-06-29召开股东大会
会议内容 ▼▲
- 1.To consider and vote upon a proposal (the “Business Combination Proposal”) to approve the Agreement and Plan of Merger, dated as of August 30, 2022 and amended as of October 14, 2022 and April 20, 2023 (as it may be further amended, supplemented or otherwise modified from time to time in accordance with its terms, the “Merger Agreement”), by and among ERES, LMA Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of ERES (“LMA Merger Sub”), Abacus Merger Sub, LLC, a Delaware limited liability company and wholly owned subsidiary of ERES (“Abacus Merger Sub” and, together with LMA Merger Sub, “Merger Subs”), Longevity Market Assets, LLC, a Florida limited liability company (“LMA”), and Abacus Settlements, LLC, a Florida limited liability company (“Abacus” and, together with LMA, the “Companies”), and the transactions contemplated thereby, pursuant to which, subject to the satisfaction or waiver of certain conditions precedent in the Merger Agreement, (i) LMA Merger Sub will merge with and into LMA, with LMA surviving such merger (the “LMA Merger”) and (ii) Abacus Merger Sub will merge with and into Abacus, with Abacus surviving such merger (the “Abacus Merger” and, together with the LMA Merger, the “Mergers” and, along with the transactions contemplated in the Merger Agreement, the “Business Combination”) and the Companies will become direct wholly owned subsidiaries of ERES. A copy of the Merger Agreement is attached to this proxy statement as Annex A-1, a copy of the First Amendment to the Agreement and Plan of Merger, dated as of October 14, 2022, (the “Amendment”) is attached to this proxy statement as Annex A-2 and a copy of the Second Amendment to the Agreement and Plan of Merger, dated as of April 20, 2023 (the “Second Amendment”) is attached to this proxy statement as Annex A-3;
2.To consider and vote upon a proposal (the “Charter Approval Proposal”) to adopt the Second Amended and Restated Certificate of Incorporation of ERES (the “Proposed Charter”) in the form attached hereto as Annex B;
3.To consider and act upon, on a non-binding advisory basis, a separate proposal (the “Governance Proposal”) with respect to certain governance provisions in the Proposed Charter in accordance with the U.S. Securities and Exchange Commission requirements;
4.To consider and for holders of ERES Class B Common Stock (as defined herein) to vote upon a proposal (the “Director Election Proposal”) to elect seven directors to serve on the Board of Directors of the Post-Combination Company (the “Board”) until the 2024 annual meeting of stockholders, in the case of Class I directors, the 2025 annual meeting of stockholders, in the case of Class II directors, and the 2026 annual meeting of stockholders, in the case of Class III directors, and, in each case, until their respective successors are duly elected and qualified;
5.To consider and vote upon a proposal (the “Nasdaq Proposal”) to approve, for purposes of complying with applicable listing rules of Nasdaq, the issuance of shares of ERES Class A Common Stock to the Company Members pursuant to the Merger Agreement;
6.To consider and vote upon a proposal (the “Incentive Plan Proposal”) to approve and adopt the Incentive Plan (as defined herein) in the form attached hereto as Annex G;
7.To consider and vote upon a proposal (the “Adjournment Proposal” and, each of the Business Combination Proposal, the Charter Approval Proposal, the Governance Proposal, the Nasdaq Proposal, the Director Election Proposal, the Incentive Plan Proposal and the Adjournment Proposal, each a “Proposal” and collectively, the “Proposals”) to approve the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Business Combination Proposal, the Charter Approval Proposal, the Director Election Proposal, the Nasdaq Proposal or the Incentive Plan Proposal.
|
| 2022-12-30 |
股东大会：
将于2023-01-20召开股东大会
会议内容 ▼▲
- 1.To amend (the “Second Extension Amendment”) the Company’s Amended and Restated Certificate of Incorporation (our “charter”) to extend the date by which the Company must consummate a business combination (as defined below) (the “Second Extension”) from January 27, 2023 (the date that is 30 months from the closing date of the Company’s initial public offering of units (the “IPO”)) to July 27, 2023 (the date that is 36 months from the closing date of the IPO) (the “Extended Date”) (the “Second Extension Amendment Proposal”).
2.A proposal to approve the adjournment of the special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes to approve the Second Extension Amendment Proposal or if we determine that additional time is necessary to effectuate the Second Extension (the “Adjournment Proposal”).
|
| 2022-07-01 |
股东大会：
将于2022-07-25召开股东大会
会议内容 ▼▲
- 1.To amend (the “Extension Amendment”) the Company’s Amended and Restated Certificate of Incorporation (our “charter”) to extend the date by which the Company must consummate a business combination (as defined below) (the “Extension”) from July 27, 2022 (the date that is 24 months from the closing date of the Company’s initial public offering of units (the “IPO”)) to January 27, 2023 (the date that is 30 months from the closing date of the IPO) (the “Extended Date”) (the “Extension Amendment Proposal”).
2.A proposal to approve the adjournment of the special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes to approve the Extension Amendment Proposal or if we determine that additional time is necessary to effectuate the Extension (the “Adjournment Proposal”).
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|